Results 11 to 20 of about 377,839 (219)

Effectiveness of interventions to improve the uptake of immunisation in primary care, with specific focus on Mumps, Measles and Rubella (MMR) [PDF]

, 2009
Background: There has been a decade of MMR vaccine uptake which is below the threshold for herd immunity for measles and large numbers of children are unprotected. The number of measles cases in England is now rising (DH, 2008).
Morrell, Jane, Topping, Annie, McCluskey, Serena, Lui, Steve   +3 more
core   +4 more sources

A Review on Rubella Vaccine: Iran (1975-2019) [PDF]

Archives of Razi Institute, 2021
The first Attenuated rubella vaccine was developed by Parkman and Meyer in 1966. Ten years later in the 1975s, the rubella vaccine was developed in Razi Vaccine and serum research institute) RVSRI).
A Shafayi, A Mohammadi
doaj   +1 more source

Measles immunity gap among reproductive-age women participating in a simulated HIV vaccine efficacy trial in Zambia

Human Vaccines & Immunotherapeutics, 2022
Measles is a vaccine-preventable viral disease whose vaccination coverage remains low in Zambia, where the target group for vaccination is children aged 9 to 18 months.
Kalonde Malama, Amanda Tichacek, Hilary Kelly, Rachel Parker, Mubiana Inambao, Tyronza Sharkey, Kristin M. Wall, William Kilembe, Matt A. Price, Pat Fast, Fran Priddy, Susan Allen   +11 more
doaj   +1 more source

Post Vaccine Rubella During a Measles Outbreak: Clinical Case

Acta Médica Portuguesa, 2021
Rubella is a vaccine preventable infection, and congenital rubella the most feared complication of this disease. Although young adult women are at greatest risk of post-vaccine rubella, this is also the group who potentially benefits the most from ...
Luísa Graça, Sara Pereira, Raquel Duro, António Sarmento   +3 more
doaj   +1 more source

A case-control study of autism and mumps-measles-rubella vaccination using the general practice research database: design and methodology. [PDF]

, 2001
BACKGROUND: An association between mumps-measles-rubella (MMR) vaccination and the onset of symptoms typical of autism has recently been suggested. This has led to considerable concern about the safety of the vaccine.
Andrew J Hall, Eric Fombonne, Fombonne, E, Fombonne Eric, Xiangning Huang, Huang, X, Smeeth Liam, Rodrigues, LC, Peter G Smith, Rodrigues Laura C, Liam Smeeth, Smith, PG, Smith Peter G, Laura C Rodrigues, Hall, AJ, Smeeth, L, Huang Xiangning, Hall Andrew J   +17 more
core   +2 more sources

Antibody responses to Hepatitis B and measles-mumps-rubella vaccines in children who received chemotherapy for acute lymphoblastic leukemia

Revista Brasileira de Hematologia e Hemoterapia, 2012
OBJECTIVE: To evaluate viral vaccine antibody levels in children with acute lymphoblastic leukemia after chemotherapy and after vaccine booster doses.
Simone Santana Viana, Gustavo Santos Araujo, Gustavo Baptista de Almeida Faro, Lana Luíza da Cruz-Silva, Carlos André Araújo-Melo, Rosana Cipolotti   +5 more
doaj   +1 more source

Reliability of medical students' vaccination histories for immunisable diseases [PDF]

, 2008
Background Medical students come into contact with infectious diseases early on their career. Immunity against vaccine-preventable diseases is therefore vital for both medical students and the patients with whom they come into contact.
René Gottschalk, Allwinn Regina, Allwinn, Regina, Gottschalk, René, Sabine Wicker, Regina Allwinn, Rabenau, Holger, Holger F Rabenau, Gottschalk René, Rabenau Holger F, Wicker, Sabine, Wicker Sabine   +11 more
core   +2 more sources

Sero-epidemiology of mumps in western Europe. [PDF]

, 2003
Six countries (Denmark, England and Wales, France, Germany, Italy and The Netherlands) conducted large serological surveys for mumps, in the mid-1990s, as part of the European Sero-Epidemiology Network (ESEN).
Edmunds, WJ, Rota, MC, Nardone, A, Miller, E, Crovari, P, Gabutti, G, Saliou, P, Tischer, A, Berbers, G, Plesner, AM, Andrews, N, Levy-Bruhl, D, Pebody, RG, van den Hof, S, GABUTTI, Giovanni, CROVARI P, ROTA MC, MILLER E., TISCHER A, LEVY BRUHL D, EDMUNDS WJ, NARDONE A, SALIOU P, ANDREWS N, VAN DEN HOF S, PEBODY RG, PLESNER AM, BERBERS G   +27 more
core   +1 more source

Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China. [PDF]

PLoS ONE, 2017
The safety of measles vaccination is of great interest and importance to public health practice and the general society. We have analyzed the adverse events following immunization (AEFIs) of currently used measles-containing vaccines (including live ...
Fan-Ya Meng, Yong Sun, Yong-Gang Shen, Hai-Feng Pan, Ji-Hai Tang, Bin-Bing Wang, Chang-Hao Wu, Dong-Qing Ye   +7 more
doaj   +1 more source

HEALTHCARE WORKERS IN BULGARIA - ARE THEY PROTECTED FROM VACCINE-PREVENTABLE INFECTIONS?

Problems of Infectious and Parasitic Diseases, 2023
Background: Healthcare workers (HCWs) are at increased risk of exposure to many viral infections, including vaccine preventable diseases (VPDs) such as measles, mumps and rubella (MMR) as compared to non-HCWs.
Radostina Stefanova, Petia Genova-Kalou, Ivona Andonova, Maria Pishmisheva-Peleva, Stefka Krumova   +4 more
doaj   +1 more source